Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Molnupiravir on COVID-19 Mortality in the Omicron Era: A Real-World Target Trial Emulation Using Complete Czech Nationwide Data

NCT07720596 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07720596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Molnupiravir on COVID-19 Mortality in the Omicron Era: A Real-World Target Trial Emulation Using Complete Czech Nationwide Data
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2